Expression of Stat3, HIF-1α and VEGF in Wilm's tumor

Chinese Journal of Contemporary Pediatrics

Volumn 9, Issue 5, 2007, Pages 461-464

  Niu, Zhi Bin ^a   Wang, Chang Lin ^a   Hou, Ying ^a   Yang, Yi ^a   Gao, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Hypoxia inducible factor 1 ; Signal transducer and activator of transcription 3; Vascular endothelial growth factor; Wilm's tumor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; STAT3 PROTEIN; VASCULOTROPIN;

ARTICLE; CANCER RISK; CANCER STAGING; CHILD; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; TUMOR VASCULARIZATION; TUMOR VOLUME; UPREGULATION;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WILMS TUMOR;

EID: 35348980098     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, et al. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas[J]. Oncogene, 2005, 24(19): 3110-3120.
2. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways[J]. Oncogene, 2005, 24(36): 5552-5560.
3. Kirkali Z, Tuzel E, Mungan MU. Recent advance in kidney cancer and metastatic disease[J]. BJU Int, 2001, 88(8): 818-824.
4. Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma[J]. Blood, 2000, 95(8): 2630-2636.
5. Chinese source.
6. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J]. Mol Cell Biol, 1992, 12(12): 5447-5454.
7. 2-dependent degradation domain via the ubiquitin-proteasome pathway[J]. Proc Natl Acad Sci U S A, 1998, 95(14): 7987-7992.
8. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics[J]. Trends Mol Med, 2002, 8(4 Suppl): S62-67.
9. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis[J]. Nature, 1998, 394(6692): 485-490.
10. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages[J]. Am J Pathol, 2000, 157(2): 411-421.
11. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, et al. Stat3 as an oncogene[J]. Cell, 1999, 98 (3): 295-303.
12. Ivanov VN, Bhoumik A, Krasilnikov M, Raz R, Owen-Schaub LB, Levy D, et al. Cooperation between STAT3 and c-jun suppresses Fas transcription[J]. Mol Cell, 2001, 7(3): 517-528.
13. Bromberg J. Stat proteins and oncogenesis[J]. J Clin Invest, 2002, 109(9): 1139-1142.